The Efficacy of HGF/VEGF Gene Therapy for Limb Ischemia in Mice with Impaired Glucose Tolerance: Shift from Angiogenesis to Axonal Growth and Oxidative Potential in Skeletal Muscle

Background: Combined non-viral gene therapy (GT) of ischemia and cardiovascular disease is a promising tool for potential clinical translation. In previous studies our group has developed combined gene therapy by vascular endothelial growth factor 165 (<i>VEGF165</i>) + hepatocyte growth factor (<i>...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Iurii S. Stafeev I, Maria A. Boldyreva, Svetlana S. Michurina, Margarita Yu. Agareva, Arina V. Radnaeva, Mikhail Yu. Menshikov, Yu-Chen Hu, Pavel I. Makarevich, Yelena V. Parfyonova
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-11-01
Serie:	Cells
Soggetti:	gene therapy plasmid limb ischemia high-fat diet obesity VEGF
Accesso online:	https://www.mdpi.com/2073-4409/11/23/3824
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!